Friedreich’s Ataxia | CHOP Research Institute

MRI Assessment of NAD+

NAD+ (nicotinamide adenine dinucleotide) is an important substance found in the body that plays a role in energy metabolism and overall health.

Cornerstone Blog

CHOP Research Paved Way for First FDA-approved Treatment for Friedreich’s Ataxia

Published on

May 19, 2023

CHOP Research Paved Way for First Approved Drug for FA

CHOP research paved the way for the first treatment for Friedreich’s ataxia (FA), an inherited neurodegenerative disease.

Cornerstone Blog

FDA Approval, Opioid-related Poisoning, Science Slam, PCORI Funding

Published on

Mar 17, 2023

In the News: FDA Approval, Opioid-related Poisoning

Learn about a first-of-its-kind FDA approval and a PCORI project that aims to turn evidence-based research into clinical practice more quickly.

Cornerstone Blog

CHOP at ASGCT, Treatment for Friedreich’s Ataxia, New Nephrology Chief

Published on

Jul 8, 2022

This week’s In the News features ASGCT meeting highlights, our new Nephrology Chief, and more.

Friedreich Ataxia Clinical Outcomes Measures

This is a multicenter natural history and clinical measure study.

Lynch Laboratory

The Lynch Lab conducts clinical, translational, and basic science research on the rare disease Friedreich ataxia

Friedreich’s Ataxia Center of Excellence

Providing comprehensive care for patients with Friedreich’s Ataxia (FA), a rare, progressive neurogenetic condition, while advancing research to improve the lives of all individuals with FA.

Cornerstone Blog

Firearms Brief, Pandemic Births, Friedreich's Ataxia Center Funding, 'Voices on Diversity'

Published on

Dec 18, 2020

This week’s In the News features firearms research, stillbirths during COVID, donations to the Friedreich’s Ataxia Center of Excellence, and postdocs highlighted for diversity.

Cornerstone Blog

Lung Repair, License Suspensions, Lymphatics Disorder, Friedreich’s Ataxia, Racism

Published on

Oct 9, 2020

In the News shares new findings on the treatment of COVID-19 complications, driving license suspensions, lymphatic disorders, and more.

The Wilson Lab studies the inherited neuro- and cardio-degenerative mitochondrial disorder, Friedreich ataxia (FA). The lab also constructed the first random shRNA-expressing libraries and is using these libraries for drug discovery in a variety of disorders.